The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. 2001

K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
Institute of Immunology, The National Hospital, N-0027 Oslo, Norway.

The T cell specific adapter protein (TSAd) encoded by the SH2D2A gene is involved in the control of T cell activation. The gene is located in the 1q21 region, which has been implicated in susceptibility to experimental allergic encephalomyelitis in the mouse. We therefore evaluated whether a polymorphic GA repeat (GA(13)-GA(33)) within the promoter region of the SH2D2A gene shows association to multiple sclerosis (MS). The frequency of the short alleles GA(13-16) was increased among 313 Norwegian MS patients compared to 277 healthy controls (0.332 vs 0.249, OR 1.5, Pc = 0.03). Transmission disequilibrium analysis in 146 Scandinavian families with at least two affected sibs showed increased transmission of GA(16) to MS patients. No linkage or association of MS to four genetic markers flanking the SH2D2A gene was observed. After activation of naive CD4(+) T cells, T cells homozygous for MS associated short alleles displayed lower level of TSAd ex vivo than T cells carrying at least one long allele, which were not associated to MS. Since the SH2D2A protein modulates T cell activation, this may be a mechanism for how short SH2D2A alleles confer susceptibility to develop MS.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002878 Chromosomes, Human, Pair 1 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 1
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000444 Aldehyde Dehydrogenase An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. This enzyme was formerly classified as EC 1.1.1.70. D-Glucuronolactone Dehydrogenase,Aldehyde Dehydrogenase (NAD(+)),Aldehyde Dehydrogenase E1,Aldehyde Dehydrogenase E2,Aldehyde-NAD Oxidoreductase,Aldehyde NAD Oxidoreductase,D Glucuronolactone Dehydrogenase,Dehydrogenase, Aldehyde,Dehydrogenase, D-Glucuronolactone
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
July 2008, Journal of neuroimmunology,
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
March 1995, Human immunology,
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
December 1994, Annals of neurology,
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
October 1979, Neurology,
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
December 2021, Nature communications,
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
March 2014, Noro psikiyatri arsivi,
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
January 1984, Annals of the New York Academy of Sciences,
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
October 1992, Lancet (London, England),
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
January 1993, Lancet (London, England),
K Z Dai, and H F Harbo, and E G Celius, and A Oturai, and P S Sørensen, and L P Ryder, and P Datta, and A Svejgaard, and J Hillert, and S Fredrikson, and M Sandberg-Wollheim, and M Laaksonen, and K M Myhr, and H Nyland, and F Vartdal, and A Spurkland
January 1987, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie,
Copied contents to your clipboard!